Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2025
... Receptor) Modulator development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration ... Read More
-
Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2025
... Receptor) Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration ... Read More
-
ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor - Pipeline Insight, 2025
... ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources ... Read More
-
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2025
... development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule ... Read More
-
Growth Hormone (GH) Agonist - Pipeline Insight, 2025
... of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the ... Read More
-
Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2025
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Interleukin-2 (IL-2) Inhibitor: ... Read More
-
Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2025
... report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline ... Read More
-
Selective COX-2 Inhibitor - Pipeline Insight, 2025
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2025
... report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline ... Read More
-
AXL Inhibitors - Pipeline Insight, 2025
... It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage AXL Inhibitors: Understanding AXL Inhibitors: ... Read More
-
Chronic inflammatory demyelinating polyneuropathy (CIDP)- Pipeline Insight, 2025
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Chronic ... Read More
-
Postmenopausal Osteoporosis - Pipeline Insight, 2025
... It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Postmenopausal Osteoporosis: Understanding Postmenopausal Osteoporosis: ... Read More
-
Guillain-Barré Syndrome (GBS) - Pipeline Insight, 2025
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Guillain-Barré Syndrome (GBS): ... Read More
-
Refractory Metastatic Melanoma - Pipeline Insight, 2025
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Refractory Metastatic Melanoma: ... Read More
-
TCR Therapy- Pipeline Insight, 2025
... also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage TCR Therapy: Understanding TCR Therapy: Overview ... Read More
-
High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User - Global Forecast to 2030
... owing to the innovations in high-resolution imaging, automation, and artificial intelligence (AI)-powered data analysis, which have significantly enhanced the efficiency and accuracy of HCS workflows. Advanced instruments equipped with high-speed fluorescence microscopy, confocal imaging, and ... Read More
-
AI in Drug Discovery Market Analysis and Forecast to 2034
... in Drug Discovery Market refers to the application of artificial intelligence technologies in the pharmaceutical industry to enhance and accelerate the process of discovering new drugs. This market is driven by the integration of machine ... Read More
-
Thailand Diabetes Devices and Therapeutics Market Investment Opportunities – Analysis & Market Size by Diagnosis and Monitoring Devices, Therapeutics, Combination Drugs, Route of Administration, Type of Diabetes, Distribution Channels, End User, Competitive Landscape – Q2 2025 Update
... a CAGR of 8.2%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 6.3% during 2025-2029. By the end of 2029, the diabetes market is projected to ... Read More
-
Canada Diabetes Devices and Therapeutics Market Investment Opportunities – Analysis & Market Size by Diagnosis and Monitoring Devices, Therapeutics, Combination Drugs, Route of Administration, Type of Diabetes, Distribution Channels, End User, Competitive Landscape – Q2 2025 Update
... a CAGR of 12.9%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 10.0% during 2025-2029. By the end of 2029, the diabetes market is projected to ... Read More
-
Argentina Diabetes Devices and Therapeutics Market Investment Opportunities – Analysis & Market Size by Diagnosis and Monitoring Devices, Therapeutics, Combination Drugs, Route of Administration, Type of Diabetes, Distribution Channels, End User, Competitive Landscape – Q2 2025 Update
... a CAGR of 8.1%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 6.3% during 2025-2029. By the end of 2029, the diabetes market is projected to ... Read More
-
Taiwan Diabetes Devices and Therapeutics Market Investment Opportunities – Analysis & Market Size by Diagnosis and Monitoring Devices, Therapeutics, Combination Drugs, Route of Administration, Type of Diabetes, Distribution Channels, End User, Competitive Landscape – Q2 2025 Update
... a CAGR of 10.1%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 7.9% during 2025-2029. By the end of 2029, the diabetes market is projected to ... Read More
-
Singapore Diabetes Devices and Therapeutics Market Investment Opportunities – Analysis & Market Size by Diagnosis and Monitoring Devices, Therapeutics, Combination Drugs, Route of Administration, Type of Diabetes, Distribution Channels, End User, Competitive Landscape – Q2 2025 Update
... a CAGR of 9.4%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 7.2% during 2025-2029. By the end of 2029, the diabetes market is projected to ... Read More
-
Turkey Diabetes Devices and Therapeutics Market Investment Opportunities – Analysis & Market Size by Diagnosis and Monitoring Devices, Therapeutics, Combination Drugs, Route of Administration, Type of Diabetes, Distribution Channels, End User, Competitive Landscape – Q2 2025 Update
... a CAGR of 8.5%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 6.7% during 2025-2029. By the end of 2029, the diabetes market is projected to ... Read More
-
Bangladesh Diabetes Devices and Therapeutics Market Investment Opportunities – Analysis & Market Size by Diagnosis and Monitoring Devices, Therapeutics, Combination Drugs, Route of Administration, Type of Diabetes, Distribution Channels, End User, Competitive Landscape – Q2 2025 Update
... a CAGR of 7.2%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 5.7% during 2025-2029. By the end of 2029, the diabetes market is projected to ... Read More
-
Vietnam Diabetes Devices and Therapeutics Market Investment Opportunities – Analysis & Market Size by Diagnosis and Monitoring Devices, Therapeutics, Combination Drugs, Route of Administration, Type of Diabetes, Distribution Channels, End User, Competitive Landscape – Q2 2025 Update
... a CAGR of 7.4%. This upward trajectory is expected to continue, with the market forecast to grow at a CAGR of 5.6% during 2025-2029. By the end of 2029, the diabetes market is projected to ... Read More
Research Assistance
